title: Dermatologic surgery into the next millennium, part II.
abstract: This is the second article in a 4-part series on dermatologic surgery. This section provides detailed information about filling agents and botulinus toxin A. The filling agents discussed here are frequently used in our office. It is emphasized that meticulous technique and patient selection predict a good cosmetic result. To select the right agent, patient safety must be a priority.
authors.affiliation: Affiliated Dermatology, Morristown, NJ 07960, USA.
authors.forename: I P
authors.initials: IP
authors.lastname: Warmuth
authors.forename: R
authors.initials: R
authors.lastname: Bader
authors.forename: D
authors.initials: D
authors.lastname: Scarborough
authors.forename: E
authors.initials: E
authors.lastname: Bisaccia
mesh_terms: D019274:Botulinum Toxins, Type A / Q000627:therapeutic use; D003869:Dermabrasion / Q000379:methods; D003879:Dermatologic Agents / Q000008:administration & dosage; D004954:Esthetics; D005260:Female; D005544:Forecasting; D006801:Humans; D008297:Male; D015361:Rhytidoplasty / Q000379:methods / Q000639:trends; D013518:Surgery, Plastic / Q000379:methods* / Q000639:trends*; D016896:Treatment Outcome; D014481:United States
chemical_list: D003879:Dermatologic Agents; D019274:Botulinum Toxins, Type A